Alberti, Marta
Alberti, Marta
SCIENZA E TECNOLOGIA DEL FARMACO
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role
2024-01-01 Elena Martino, Stefano Sainas, Iole Manella, Marta Alberti, Marta Giorgis, Paola Circosta, Donatella Boschi and Marco Lucio Lolli
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role.
2024-01-01 Elena Martino, Stefano Sainas, Marta Alberti, Iole Mannella, Marta Giorgis, Paola Circosta, Donatella Boschi, Marco Lucio Lolli
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2- hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic
2022-01-01 Marta Giorgis, Stefano Sainas, Paola Circosta, Alice Passoni, Renzo Bagnati, Marilena Marraudino, Brigitta Bonaldo, Stefano Gotti, Riccardo Miggiano, Davide Ferraris, Marta Alberti, Agnese Chiara Pippione, Chiara Vigato, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Targeting dihydroorotate dehydrogenase (DHODH) in anti-infective research: focusing in the design of on anti-malarial and anti-tuberculosis agents
2021-01-01 Marco Lucio Lolli, Agnese Chiara Pippione, Riccardo Miggiano, Davide Ferraris, Marta Giorgis, Marta Alberti, Noemi Villella, Stefano Sainas, Salam Al-Karadaghi, Donatella Boschi
Targeting Plasmodium falciparum dihydroorotate dehydrogenase: design, synthesis, co-crystallization and biological evaluation of new 3-hydroxypyrazole scaffold-based inhibitors
2022-01-01 Noemi Villella, Agnese Chiara Pippione, Stefano Sainas, Marta Giorgis, Giulio Poli, Tiziano Tuccinardi, Marta Alberti, Riccardo Miggiano, Davide Maria Ferraris, Luca Marchisio, Sandrine Cojean, Efrain Salamanca, Alberto Jose Gimenez, Barbara Buccinnà, Cristina Ramondetti, Marco Piccinini, Marco Lucio Lolli, Donatella Boschi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role | 2024 | Elena Martino, Stefano Sainas, Iole Manella, Marta Alberti, Marta Giorgis, Paola Circosta, Donatella Boschi and Marco Lucio Lolli | |
Investigation of the central core of MEDS433: A Bioisosteric voyage into the Amide's Role. | 2024 | Elena Martino, Stefano Sainas, Marta Alberti, Iole Mannella, Marta Giorgis, Paola Circosta, Donatella Boschi, Marco Lucio Lolli | |
Targeting Acute Myelogenous Leukemia using potent human dihydroorotate dehydrogenase inhibitors based on the 2- hydroxypyrazolo[1,5-a]pyridine scaffold: from academy to clinic | 2022 | Marta Giorgis, Stefano Sainas, Paola Circosta, Alice Passoni, Renzo Bagnati, Marilena Marraudino, Brigitta Bonaldo, Stefano Gotti, Riccardo Miggiano, Davide Ferraris, Marta Alberti, Agnese Chiara Pippione, Chiara Vigato, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli | |
Targeting dihydroorotate dehydrogenase (DHODH) in anti-infective research: focusing in the design of on anti-malarial and anti-tuberculosis agents | 2021 | Marco Lucio Lolli, Agnese Chiara Pippione, Riccardo Miggiano, Davide Ferraris, Marta Giorgis, Marta Alberti, Noemi Villella, Stefano Sainas, Salam Al-Karadaghi, Donatella Boschi | |
Targeting Plasmodium falciparum dihydroorotate dehydrogenase: design, synthesis, co-crystallization and biological evaluation of new 3-hydroxypyrazole scaffold-based inhibitors | 2022 | Noemi Villella, Agnese Chiara Pippione, Stefano Sainas, Marta Giorgis, Giulio Poli, Tiziano Tuccinardi, Marta Alberti, Riccardo Miggiano, Davide Maria Ferraris, Luca Marchisio, Sandrine Cojean, Efrain Salamanca, Alberto Jose Gimenez, Barbara Buccinnà, Cristina Ramondetti, Marco Piccinini, Marco Lucio Lolli, Donatella Boschi |